C2-substituted indan-1-ols and their derivatives, processes for their preparation and their use as pharmaceuticals

US7015208B2 · kind B2 · utility

Assignee

• Aventis Pharma Deutschland GmbH · DE

Inventors

• Gerhard Jaehne · Frankfurt, DE
• Volker Krone · Flörsheim, DE
• Martin Bickel · Frankfurt am Main, DE
• Matthias Gossel · Frankfurt am Main, DE

Key dates

• Filing date: Nov 4, 2004
• Grant date: Mar 21, 2006
• Expiry date: Feb 26, 2025

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2602/08
• WIPO field: Organic fine chemistry
• WIPO sector: Chemistry

Abstract

Embodiments of the invention relate to C2-substituted indan-1-ols and to their physiologically acceptable salts and physiologically functional derivatives. Compounds of embodiments of the invention may include compounds of formula I in which the radicals are as defined, and their physiologically acceptable salts and processes for their preparation. The compounds are suitable, for example, for use as anorectics.